A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia (Q33402939)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia |
scientific article |
Statements
1 reference
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia (English)
1 reference
Martin Tallman
1 reference
Elisabeth Paietta
1 reference
Frederick R Appelbaum
1 reference
Jerald P Radich
1 reference
Kenneth J Kopecky
1 reference
Wendy Stock
1 reference
Greg Malnassy
1 reference
Jeff Lipton
1 reference
A Robert Turner
1 reference
Michael Deininger
1 reference
22 August 2012
1 reference
1 reference
120
1 reference
19
1 reference
3898-3905
1 reference
Identifiers
1 reference
1 reference
1 reference